Besides, targeting of CD133-positive cancer stem cells (CSCs) by MSC-TRAIL showed a prospective role of modifying apoptosis-related genes in non-small cell lung cancer (NSCLC) (Fakiruddin et al., 2019). The gene discussed is TNFSF10; the disease is cancer.